retatrutide weight loss clinical trial results Peptide Series #3 — 🧬🏃🏻‍♀️ BOOM🔥! The most POWERFUL DRUG EVER tested in a isn't approved yet. But the data is already rewriting what we thought was Retatrutide hits 28.3% weight loss

Side effects were reportedly similar to GLP-1 medications, most commonly including gastrointestinal complications like nausea, vomiting and diarrhea

As a result, clinicians may begin therapy earlier, potentially improving outcomes and preventing complications

Because fats naturally slow gastric emptying even in individuals not taking semaglutide, the combined effect with the medication can lead to prolonged feelings of uncomfortable fullness, nausea, and sometimes vomiting

On Monday, Novo Nordisk said it is suing Hims, asking the court to permanently ban the company from selling compounded versions of its drugs that infringe on Novos patents